-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Boston Scientific, Lowers Price Target to $62

Benzinga·07/16/2026 15:39:56
Listen to the news
Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $64 to $62.